|
Bristol-Myers Squibb - Pfizer Alliance ACROPOLIS™ real-world data program grows to sample size of nearly one million lives worldwide
|
20 August 2018 |
|
Bristol-Myers Squibb announces worldwide collaboration with Janssen to develop and commercialize next-generation cardiovascular therapy
|
16 April 2018 |
|
Bristol-Myers Squibb and Harvard announce new fibrosis research collaboration
|
12 April 2018 |
|
Bristol-Myers Squibb's Opdivo® (nivolumab) now the first and only FDA-approved PD-1 inhibitor to offer every four-week dosing
|
07 March 2018 |
|
Bristol-Myers Squibb announces expansion of the International Immuno-Oncology Network (II-ON) with addition of Yale Cancer Center
|
01 March 2018 |
|
Bristol-Myers Squibb and Nektar Therapeutics announce global development & commercialization collaboration for Nektar's CD122-biased agonist, NKTR-214
|
15 February 2018 |
|
Bristol-Myers Squibb and Pfizer Alliance urge people to 'Tune in to AFib, Take Note of Stroke Risk'
|
05 December 2017 |
|
Bristol-Myers Squibb awards "Golden Tickets" for LabCentral to Neutrolis, Remora Therapeutics
|
28 November 2017 |
|
BMS-Pfizer Alliance to unveil real-world data analyses - cost, safety and comparative effectiveness findings associated with oral anticoagulants in non-valvular atrial fibrillation
|
10 November 2017 |
|
FDA accepts Bristol-Myers Squibb's application for Opdivo (nivolumab) in patients with resected high-risk advanced melanoma and grants priority review
|
17 October 2017 |
|
Caregivers wish liver cancer received greater public awareness in the U.S., new survey reveals
|
04 October 2017 |
|
AbbVie and Bristol-Myers Squibb announce clinical research collaboration to evaluate a therapeutic regimen in advanced solid tumors
|
22 September 2017 |
|
Bristol-Myers Squibb and Halozyme enter global collaboration and license agreement for ENHANZE technology
|
14 September 2017 |
|
Bristol-Myers Squibb completes previously announced acquisition of IFM Therapeutics
|
07 September 2017 |
|
Bristol-Myers Squibb employees ride across the U.S. to raise money to support cancer research by Stand Up To Cancer
|
06 September 2017 |
|
Bristol-Myers Squibb announces topline results from CheckMate -214
|
15 August 2017 |
|
Bristol-Myers Squibb to acquire IFM Therapeutics to strengthen oncology pipeline focus on innate immunity
|
03 August 2017 |
|
Bristol-Myers Squibb and Clovis Oncology announce a broad clinical collaboration
|
31 July 2017 |
|
U.S. Food and Drug Administration expands approval of Yervoy® (ipilimumab) to include pediatric patients 12 years and older with unresectable or metastatic melanoma
|
24 July 2017 |
|
Bristol-Myers Squibb to sell manufacturing facility in Swords, Ireland to SK Biotek Co., Ltd.
|
16 June 2017 |